Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Data Unavailable

Employees

1,644

Website

www.daewoong.com

IPO Date

2005-09-29

Headquarters

12, Bongeunsa-ro 114-gil, Gangnam-gu, Seoul 135-715, South Korea

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Daewoong Pharmaceutical A069620

Daewoong Pharmaceutical Earnings Call Summary

Daewoong Pharmaceutical Earnings

Transcripts

Events

About Daewoong Pharmaceutical Co., Ltd

Daewoong Pharmaceutical
A069620